Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Mining_Engineer_UBCon Mar 28, 2019 12:53pm
108 Views
Post# 29549043

RE:stopped out today

RE:stopped out todayI feel your pain edmed. And its an act of courage to sell at what I'm assuming is a loss. For others still holding TRPX I will say that although this financing deal is not on the greatest of terms, it does obviously buy us some time to further advance our research and hopefully line up a merger/acquisition deal. In that sense this news reducing the risk profile in the near term as the risk of bankruptcy has dropped dramatically. Only time will tell if the dilution price was too high, and like many shareholders I am becoming increasingly impatient with this management team.
<< Previous
Bullboard Posts
Next >>